These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32185791)

  • 21. Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome.
    Lattanzi S; Zaccara G; Russo E; La Neve A; Lodi MAM; Striano P
    Expert Rev Neurother; 2021 Jan; 21(1):99-110. PubMed ID: 33026899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of new medical treatments for the management of developmental and epileptic encephalopathies: Novel concepts and results.
    Johannessen Landmark C; Potschka H; Auvin S; Wilmshurst JM; Johannessen SI; Kasteleijn-Nolst Trenité D; Wirrell EC
    Epilepsia; 2021 Apr; 62(4):857-873. PubMed ID: 33638459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Kanner AM; Ashman E; Gloss D; Harden C; Bourgeois B; Bautista JF; Abou-Khalil B; Burakgazi-Dalkilic E; Llanas Park E; Stern J; Hirtz D; Nespeca M; Gidal B; Faught E; French J
    Neurology; 2018 Jul; 91(2):82-90. PubMed ID: 29898974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigational cannabinoids in seizure disorders, what have we learned thus far?
    Ružić Zečević D; Folić M; Tantoush Z; Radovanović M; Babić G; Janković SM
    Expert Opin Investig Drugs; 2018 Jun; 27(6):535-541. PubMed ID: 29842819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy.
    Kochen S; Villanueva M; Bayarres L; Daza-Restrepo A; Gonzalez Martinez S; Oddo S
    Epilepsy Behav; 2023 Jul; 144():109210. PubMed ID: 37196452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of cannabidiol in children with refractory epileptic encephalopathy.
    Cáceres Guido P; Riva N; Caraballo R; Reyes G; Huaman M; Gutierrez R; Agostini S; Fabiana Delaven S; Pérez Montilla CA; García Bournissen F; Schaiquevich P
    Epilepsia; 2021 Jan; 62(1):e7-e12. PubMed ID: 33280111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of cannabidiol in the treatment of epilepsy.
    Mazurkiewicz-Bełdzińska M; Zawadzka M
    Neurol Neurochir Pol; 2022; 56(1):14-20. PubMed ID: 35211946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabidiol (Epidiolex) for epilepsy.
    Med Lett Drugs Ther; 2018 Nov; 60(1559):182-184. PubMed ID: 30681657
    [No Abstract]   [Full Text] [Related]  

  • 29. Cannabidiol in the Treatment of Epilepsy.
    von Wrede R; Helmstaedter C; Surges R
    Clin Drug Investig; 2021 Mar; 41(3):211-220. PubMed ID: 33559102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the role of cannabidiol in refractory epilepsy?
    LaFleur KM; Nemec EC
    JAAPA; 2019 Mar; 32(3):16-18. PubMed ID: 30817475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We Out of the Haze?
    Yang YT; Szaflarski JP
    JAMA Neurol; 2019 Feb; 76(2):135-136. PubMed ID: 30452525
    [No Abstract]   [Full Text] [Related]  

  • 32. Cannabinoids for epilepsy: What do we know and where do we go?
    Brodie MJ; Ben-Menachem E
    Epilepsia; 2018 Feb; 59(2):291-296. PubMed ID: 29214639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stiripentol for the treatment of seizures in Dravet syndrome.
    Eschbach K; Knupp KG
    Expert Rev Clin Pharmacol; 2019 May; 12(5):379-388. PubMed ID: 31017478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
    Patsalos PN; Szaflarski JP; Gidal B; VanLandingham K; Critchley D; Morrison G
    Epilepsia; 2020 Sep; 61(9):1854-1868. PubMed ID: 32918835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in pharmacotherapy for epilepsy.
    Pong AW; Xu KJ; Klein P
    Curr Opin Neurol; 2023 Apr; 36(2):77-85. PubMed ID: 36762638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy.
    Samanta D
    Pediatr Neurol; 2019 Jul; 96():24-29. PubMed ID: 31053391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of cannabidiol as a treatment for severe childhood epilepsies.
    Williams CM; Stephens GJ
    Br J Pharmacol; 2020 Dec; 177(24):5509-5517. PubMed ID: 32986848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology and drug interactions of cannabinoids.
    Landmark CJ; Brandl U
    Epileptic Disord; 2020 Jan; 22(S1):16-22. PubMed ID: 31941642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol for Epilepsy: New Hope on the Horizon?
    Sanmartin PE; Detyniecki K
    Clin Ther; 2018 Sep; 40(9):1438-1441. PubMed ID: 30150078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality improvement study in epilepsy patients treated with Epidiolex®.
    Mora Rodriguez KA; Bhatia S; Cobb LH; Leatheng C; Kutluay E
    J Neurol Sci; 2023 Aug; 451():120712. PubMed ID: 37390612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.